140 related articles for article (PubMed ID: 31661188)
1. Impact of insurance on survival in patients < 65 with head & neck cancer treated with radiotherapy.
Sittig MP; Luu M; Yoshida EJ; Scher K; Mita A; Shiao SL; Lu DJ; Mallen-St Clair J; Ho AS; Zumsteg ZS
Clin Otolaryngol; 2020 Jan; 45(1):63-72. PubMed ID: 31661188
[TBL] [Abstract][Full Text] [Related]
2. The impact of health insurance status on the survival of patients with head and neck cancer.
Kwok J; Langevin SM; Argiris A; Grandis JR; Gooding WE; Taioli E
Cancer; 2010 Jan; 116(2):476-85. PubMed ID: 19937673
[TBL] [Abstract][Full Text] [Related]
3. Impact of concomitant chemoradiation on survival for patients with T1-2N1 head and neck cancer.
Zumsteg ZS; Kim S; David JM; Yoshida EJ; Tighiouart M; Shiao SL; Scher K; Mita A; Sherman EJ; Lee NY; Ho AS
Cancer; 2017 May; 123(9):1555-1565. PubMed ID: 28001302
[TBL] [Abstract][Full Text] [Related]
4. Impact of Race and Insurance Status on Primary Treatment for HPV-Associated Oropharyngeal Squamous Cell Carcinoma.
Habib AM; Carey RM; Prasad A; Mady LJ; Shinn JR; Bur AM; Brody RM; Cannady SB; Rajasekaran K; Ibrahim SA; Newman JG; Brant JA
Otolaryngol Head Neck Surg; 2022 Jun; 166(6):1062-1069. PubMed ID: 34253112
[TBL] [Abstract][Full Text] [Related]
5. The impact of underinsurance on bladder cancer diagnosis, survival, and care delivery for individuals under the age of 65 years.
Fletcher SA; Cole AP; Lu C; Marchese M; Krimphove MJ; Friedlander DF; Mossanen M; Kilbridge KL; Kibel AS; Trinh QD
Cancer; 2020 Feb; 126(3):496-505. PubMed ID: 31626340
[TBL] [Abstract][Full Text] [Related]
6. Hypofractionated radiotherapy alone with 2.4 Gy per fraction for head and neck cancer during the COVID-19 pandemic: The Princess Margaret experience and proposal.
Huang SH; O'Sullivan B; Su J; Ringash J; Bratman SV; Kim J; Hosni A; Bayley A; Cho J; Giuliani M; Hope A; Spreafico A; Hansen AR; Siu LL; Gilbert R; Irish JC; Goldstein D; de Almeida J; Tong L; Xu W; Waldron J
Cancer; 2020 Aug; 126(15):3426-3437. PubMed ID: 32478895
[TBL] [Abstract][Full Text] [Related]
7. Treatment at high-volume facilities and academic centers is independently associated with improved survival in patients with locally advanced head and neck cancer.
David JM; Ho AS; Luu M; Yoshida EJ; Kim S; Mita AC; Scher KS; Shiao SL; Tighiouart M; Zumsteg ZS
Cancer; 2017 Oct; 123(20):3933-3942. PubMed ID: 28640546
[TBL] [Abstract][Full Text] [Related]
8. Impact of the insurance type of head and neck cancer patients on their hospitalization utilization patterns.
Gupta A; Sonis ST; Schneider EB; Villa A
Cancer; 2018 Feb; 124(4):760-768. PubMed ID: 29112234
[TBL] [Abstract][Full Text] [Related]
9. Insurance Status as a Predictor of Treatment in Human Papillomavirus Positive Oropharyngeal Cancer.
Berger MH; Yasaka TM; Haidar YM; Kuan EC; Tjoa T
Laryngoscope; 2021 Apr; 131(4):776-781. PubMed ID: 32790156
[TBL] [Abstract][Full Text] [Related]
10. Health Insurance Affects Head and Neck Cancer Treatment Patterns and Outcomes.
Inverso G; Mahal BA; Aizer AA; Donoff RB; Chuang SK
J Oral Maxillofac Surg; 2016 Jun; 74(6):1241-7. PubMed ID: 26851312
[TBL] [Abstract][Full Text] [Related]
11. Adjuvant Chemoradiation After Surgical Resection in Elderly Patients With High-Risk Squamous Cell Carcinoma of the Head and Neck: A National Cancer Database Analysis.
Woody NM; Ward MC; Koyfman SA; Reddy CA; Geiger J; Joshi N; Burkey B; Scharpf J; Lamarre E; Prendes B; Adelstein DJ
Int J Radiat Oncol Biol Phys; 2017 Jul; 98(4):784-792. PubMed ID: 28602410
[TBL] [Abstract][Full Text] [Related]
12. Association of the Patient Protection and Affordable Care Act With Insurance Coverage for Head and Neck Cancer in the SEER Database.
Cannon RB; Shepherd HM; McCrary H; Carpenter PS; Buchmann LO; Hunt JP; Houlton JJ; Monroe MM
JAMA Otolaryngol Head Neck Surg; 2018 Nov; 144(11):1052-1057. PubMed ID: 30242321
[TBL] [Abstract][Full Text] [Related]
13. Proton radiotherapy and treatment delay in head and neck squamous cell carcinoma.
Jin MC; Harris JP; Sabolch AN; Gensheimer M; Le QT; Beadle BM; Pollom EL
Laryngoscope; 2020 Nov; 130(11):E598-E604. PubMed ID: 31837165
[TBL] [Abstract][Full Text] [Related]
14. HPV Status and Survival in Non-Oropharyngeal Squamous Cell Carcinoma of the Head and Neck.
Wookey VB; Appiah AK; Kallam A; Ernani V; Smith LM; Ganti AK
Anticancer Res; 2019 Apr; 39(4):1907-1914. PubMed ID: 30952732
[TBL] [Abstract][Full Text] [Related]
15. Impact of payer status on survival in parotid malignancy.
Stubbs VC; Rajasekaran K; Chen J; Cannady SB; Brant JA; Newman JG
Am J Otolaryngol; 2019; 40(4):555-559. PubMed ID: 31097206
[TBL] [Abstract][Full Text] [Related]
16. Survival outcomes by high-risk human papillomavirus status in nonoropharyngeal head and neck squamous cell carcinomas: A propensity-scored analysis of the National Cancer Data Base.
Tian S; Switchenko JM; Jhaveri J; Cassidy RJ; Ferris MJ; Press RH; Pfister NT; Patel MR; Saba NF; McDonald MW; Higgins KA; Yu DS; Curran WJ; Gillespie TW; Beitler JJ
Cancer; 2019 Aug; 125(16):2782-2793. PubMed ID: 31012957
[TBL] [Abstract][Full Text] [Related]
17. Platinum-based regimens versus cetuximab in definitive chemoradiation for human papillomavirus-unrelated head and neck cancer.
Beckham TH; Barney C; Healy E; Wolfe AR; Branstetter A; Yaney A; Riaz N; McBride SM; Tsai CJ; Kang J; Yu Y; Chen L; Sherman E; Dunn L; Pfister DG; Tan J; Rupert R; Bonomi M; Zhang Z; Lobaugh SM; Grecula JC; Mitchell DL; Wobb JL; Miller ED; Blakaj DM; Diavolitsis VM; Lee N; Bhatt AD
Int J Cancer; 2020 Jul; 147(1):107-115. PubMed ID: 31609479
[TBL] [Abstract][Full Text] [Related]
18. Definitive radiation with concurrent cetuximab vs. radiation with or without concurrent cytotoxic chemotherapy in older patients with squamous cell carcinoma of the head and neck: Analysis of the SEER-medicare linked database.
Zandberg DP; Cullen K; Bentzen SM; Goloubeva OG
Oral Oncol; 2018 Nov; 86():132-140. PubMed ID: 30409293
[TBL] [Abstract][Full Text] [Related]
19. Association of insurance status with survival in patients with cutaneous T-cell lymphoma.
Tang R; Su C; Bai HX; Zeng Z; Karakousis G; Zhang PJ; Zhang G; Xiao R
Leuk Lymphoma; 2019 May; 60(5):1253-1260. PubMed ID: 30326769
[TBL] [Abstract][Full Text] [Related]
20. Association of Human Papillomavirus Status at Head and Neck Carcinoma Subsites With Overall Survival.
Li H; Torabi SJ; Yarbrough WG; Mehra S; Osborn HA; Judson B
JAMA Otolaryngol Head Neck Surg; 2018 Jun; 144(6):519-525. PubMed ID: 29801040
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
